Almac Group announces PhD scholarship at UCL

This investment follows the company’s announcement it completed an R&D centre within which its programme to accelerate enzyme discovery is currently underway

picture of

Breaking News

Long-term toxicology studies confirm MP1032 safety profile

MetrioPharm's lead compound has been evaluated in dogs and rats, confirming its "very good tolerability"

Merck and SignalChem to investigate combination tumour treatment

The companies will evaluate SignalChem’s SLC-391 in combination with Merck’s Keytruda (pembrolizumab) in the ...

IONTAS identifies SARS-CoV-2 variant neutralising antibodies

The company is now seeking development partners to progress the antibodies

Five challenges for AAV developers

Bio-Rad experts Mark White, Associate Director of Biopharma Product Marketing, and Marwan Alsarraj, BioPharma Segment ...

Celonic Group and UCL announce partnership

The agreement gives UCL access to Celonic’s CHOvolution platform

UK Government invests in CPI to develop vaccine library

When variants of COVID-19 are identified, their DNA can be used to develop mRNA vaccines in a matter of days, CPI says

From dark art to an age of enlightenment

Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...

Aptamer Group extends collaboration with AstraZeneca

The collaboration aims to develop drug delivery approaches based on Aptamer’s Optimer platform

Bormioli Pharma to open glass research centre

"With this project, we aim to create a centre of excellence for innovation in glass containers for drugs with high ...

SLIM-based HRIM-MS: the future of challenging separations

High Resolution Ion Mobility Mass Spectrometry (HRIM-MS) based on Structures for Lossless Ion Manipulation (SLIM) has ...

The application of picodroplet technology for biopharmaceutical discovery and scientific research

Picodroplet technologies continue to push the boundaries of biologic discovery by accelerating research, expanding the ...

Towards the enzymatic synthesis of oligonucleotides: part II

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, ...

Pfizer partners with Medicines Manufacturing Innovation Centre

The company will be participating in the centre’s first ‘grand challenge,’ aiming to develop a continuous direct ...

SB3000 awarded grant for continuous manufacturing technology

The μLOT technology can reportedly reduce the environmental impact of medicine production and ensure consistent ...